Search results for "OBESITY"

showing 10 items of 1833 documents

The Social Nature of Chronic Noncommunicable Diseases and How to Tackle Them Through Communication Technology, Training, and Outreach

2011

As world leaders prepare for the United Nations High Level Meeting on Noncommunicable Diseases, to take place in September 2011, international organizations, nongovernmental organizations, and economic and business fora have created new alliances and initiatives to accelerate research, advocacy, and political commitment. This article argues that the time is propitious to reflect on the social nature of the most common behavioral noncommunicable disease determinants, including tobacco and alcohol use, physical inactivity, and unhealthy diet. Evidence is presented related to the fact that these diseases are profoundly rooted in social and community ties and points to the need for a modern com…

Economic growthmedicine.medical_specialtyHealth (social science)Alcohol DrinkingOccupational Health ServicesSmoking PreventionHealth literacyHealth PromotionLibrary and Information SciencesVulnerable PopulationsHealth informaticsHumansMedicineObesitySocial BehaviorHealth communicationbusiness.industryCommunicationPublic healthSmokingSocial naturePublic Health Environmental and Occupational HealthPublic relationsNew mediaDietHealth LiteracyOutreachHealth CommunicationChronic DiseaseWorkforceSedentary BehaviorbusinessMedical InformaticsJournal of Health Communication
researchProduct

Orexin system: Network multi-tasking

2018

Orexin system regulates sleep/wake states and its deficiency result in narcolepsy thus indicating the crucial role of orexins in maintaining wakefulness. There are two types of orexin peptides: the orexin-A (OXA or hypocretin 1) and orexin-B (OXB or hypocre- tin 2). The Majority of the central nervous system orexin peptides are synthesized in neurons located in the lateral and back hypotha- lamus and send projections throughout the brain regions Orexin neurons are “multi-tasking” hence regulating also energy homeosta- sis, reward systems and feeding behaviour through connection with hypothalamic nuclei and through responsiveness to leptine and glucose. It has recently been found a connectio…

Emotional stress; Narcolepsy; Obesity; OrexinEmotional stress; Narcolepsy; Obesity; Orexin; Medicine (all)Medicine (all)digestive oral and skin physiologyEmotional stressSettore MED/39 - Neuropsichiatria InfantileEmotional streSettore M-PSI/04 - Psicologia Dello Sviluppo E Psicologia Dell'Educazionenervous systemmental disordersOrexinObesityhormones hormone substitutes and hormone antagonistspsychological phenomena and processesNarcolepsy
researchProduct

The effect of weight on labor market outcomes: An application of genetic instrumental variables

2019

This paper contributes to the literature on the labor market consequences of obesity by using a novel instrument: genetic risk score, which reflects the predisposition to higher body mass index (BMI) across many genetic loci. We estimate instrumental variable models of the effect of BMI on labor market outcomes using Finnish data that have many strengths, for example, BMI that is measured rather than self‐reported, and data on earnings and social income transfers that are from administrative tax records and are thus free of the problems associated with nonresponse, reporting error or top coding. The empirical results are sensitive to whether we use a narrower or broader genetic risk score, …

EmploymentsosiaaliturvaobesitytulonsiirrotKansanterveystiede ympäristö ja työterveys - Public health care science environmental and occupational healthJ01J24Body Mass IndexI10502 economics and businessHumansoverweightgeneticssocial income transfers050207 economicsFinlandResearch Articlesansiotulot050208 financeperinnöllisyystiedeSalaries and Fringe BenefitsI12Body Weight05 social sciencestyöllisyysylipainogenetiset tekijätModels EconomicD62J78. Economic growthIncomeJ3lihavuusearningsResearch Article
researchProduct

Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Stud…

2022

Introduction The glucagon-like peptide-1 agonist (GLP1-RA) liraglutide is currently approved for the treatment of both obesity and type 2 diabetes (T2DM). We investigated whether the effect of this agent on cardiometabolic parameters in subjects with T2DM varied in relation to the concomitant presence of obesity. Methods One hundred thirty-five subjects (78 men and 57 women; age: 62 +/- 10 years) naive to incretin-based therapies were treated with low-dose liraglutide (1.2 mg/day) as an add-on to metformin for 18 months. Patients were divided into two subgroups based on their body-mass index (BMI): (a) obese (BMI >= 30) and (b) non-obese (BMI < 30). Clinical and laboratory analyses we…

Endocrinology Diabetes and MetabolismInternal MedicineCardiovascular risk Carotid intima–media thickness GLP-1 Incretins Liraglutide Obesity Type 2 diabetes mellitusDiabetes therapy : research, treatment and education of diabetes and related disorders
researchProduct

The effects of muscle mass and muscle quality on cardio-metabolic risk in peripubertal girls: a longitudinal study from childhood to early adulthood.

2017

Increased cardio-metabolic risk is well documented in children and adolescents with obesity and normal weight obesity (NWO). However, the associations of muscle mass and muscle quality with cardio-metabolic risk, independent of weight status from childhood to adulthood, has not been examined. A total of 236 girls were followed from pre-puberty to early adulthood. Fat mass (FM) and lean mass (LM) of the whole body were assessed by a dual-energy X-ray absorptiometry; muscle cross-sectional area (mCSA), muscle density (mDen; skeletal muscle fat content) of the lower leg by the peripheral quantitative computerized tomography; and blood glucose, insulin, triglycerides and high-density lipoprotei…

Endocrinology Diabetes and Metabolismmedicine.medical_treatmentlongitudinal researchMedicine (miscellaneous)030204 cardiovascular system & hematologyOverweightBody Mass Index0302 clinical medicineRisk FactorsLongitudinal StudiesChildrasva-arvotNutrition and DieteticsFramingham Risk Scoregirlsta3141tytötNormal weight obesitymedicine.anatomical_structuremuscle massAdipose TissueCardiovascular DiseasesFemalemedicine.symptommedicine.medical_specialtyAdolescentblood sugar030209 endocrinology & metabolismpitkittäistutkimus03 medical and health sciencesInternal medicinemedicinefatty acid levelsHumansObesityMuscle Skeletalkehonkoostumusbody compositionbusiness.industryInsulinSkeletal muscleOverweightmedicine.diseaseObesityEndocrinologylihasmassaverensokeriLean body massbusinessBody mass indexInternational journal of obesity (2005)
researchProduct

Genetic and Epigenetic Biomarkers for Diagnosis, Prognosis and Treatment of Metabolic Syndrome.

2021

Background: Metabolic syndrome is a clinical condition that deserves special attention because it puts the individual at high cardiovascular risk, especially heart attack and stroke. Considering precision medicine, it would be advisable to evaluate the individual cardio-metabolic risk by estimating the coexistence of risk factors (abdominal obesity, low level of High-Density Lipoprotein Cholesterol, High Triglycerides, and small dense Low-Density Lipoproteins sub-classes, hypertension, and elevated fasting glycemia), which could engrave on metabolism increasing cardiovascular mortality. Objective: To identify genetic and epigenetic biomarkers may assist in the possibility of helping follow…

EpigenomicsBioinformaticsEpigenesis GeneticGeneticDrug DiscoverymedicineHumansEpigeneticsAbdominal obesityPharmacologyInflammationMetabolic Syndromebusiness.industryEpigeneticEpigenomeDNA MethylationPrecision medicinemedicine.diseasePrognosisManagementDNA methylationHuman genomePersonalized medicineMetabolic Pathwaysmedicine.symptomMetabolic syndromebusinessBiomarkersCurrent pharmaceutical design
researchProduct

Epigenomics and metabolomics reveal the mechanism of the APOA2-saturated fat intake interaction affecting obesity

2018

BACKGROUND: The putative functional variant −265T>C (rs5082) within the APOA2 promoter has shown consistent interactions with saturated fatty acid (SFA) intake to influence the risk of obesity. OBJECTIVE: The aim of this study was to implement an integrative approach to characterize the molecular basis of this interaction. DESIGN: We conducted an epigenome-wide scan on 80 participants carrying either the rs5082 CC or TT genotypes and consuming either a low-SFA (C genotype, promoting an APOA2 expression difference between APOA2 genotypes on a high-SFA diet, and modulating BCAA and tryptophan metabolic pathways. These findings identify potential mechanisms by which this highly reproducible ge…

EpigenomicsMale0301 basic medicineGenotypeMedicine (miscellaneous)030204 cardiovascular system & hematologyBiologyBioinformatics03 medical and health sciences0302 clinical medicineFramingham Heart StudyMetabolomicsGenotypemedicineHumansMetabolomicsDrug InteractionsObesityEpigeneticsAgedEpigenomicsNutrition and DieteticsApolipoprotein A-Ifood and beveragesGenetic VariationEpigenomeDNA MethylationMiddle AgedLipid Metabolismmedicine.diseaseDietary FatsObesityOriginal Research Communications030104 developmental biologyGene Expression RegulationSaturated fatty acidCpG IslandsFemaleApolipoprotein A-IIThe American Journal of Clinical Nutrition
researchProduct

Obesity and Cardiometabolic Risk Factors : from Childhood to Adulthood

2021

Obesity has become a major epidemic in the 21st century. It increases the risk of dyslipidemia, hypertension, and type 2 diabetes, which are known cardiometabolic risk factors and components of the metabolic syndrome. Although overt cardiovascular (CV) diseases such as stroke or myocardial infarction are the domain of adulthood, it is evident that the CV continuum begins very early in life. Recognition of risk factors and early stages of CV damage, at a time when these processes are still reversible, and the development of prevention strategies are major pillars in reducing CV morbidity and mortality in the general population. In this review, we will discuss the role of well-known but also …

EpigenomicsMaleGerontologyPediatric ObesityobesityInfants Alimentacióobesity ; cardiometabolic risk factors ; hypertension ; dyslipidemia ; tracking phenomenon ; nutrigenomicsReviewType 2 diabetesnutrigenomicPregnancytracking phenomenon.TX341-641ChildPrenatal Nutritional Physiological PhenomenaMetabolic Syndromeeducation.field_of_studyNutrition and Dieteticscardiometabolic risk factorNutrigenomicsCardiorespiratory FitnessCardiovascular DiseasesChild PreschoolObesitatFemaleAdulttracking phenomenonhypertensionAdolescentPopulationChildhood obesityYoung AdultnutrigenomicsmedicineMortalitatHumansAdultseducationbusiness.industryNutrition. Foods and food supplydyslipidemiaInfant NewbornInfantCardiorespiratory fitnessmedicine.diseaseObesitycardiometabolic risk factorsDietMetabolic syndromebusinessDyslipidemiaFood Science
researchProduct

Rheological blood behaviour is not related to gender in morbidly obese subjects.

2012

To the Editor. We have read with interest the recently published article by Wiewiora et al. [7] regarding hemorheological differences related to gender in morbidly obese subjects. In this study authors found several hemorheological differences between male and female. In this sense, males showed higher blood viscosity and higher erythrocyte deformability than females and native blood viscosity correlated with several erythrocyte aggregation parameters evaluated with the Laser-Assisted Optical Rotational Cell Analyser (LORCA) [3]. In studies with small sample sizes (18 men and 20 women) there is always the risk that differences in certain variables may appear by chance or by imbalances in th…

Erythrocyte AggregationMalePhysiologybusiness.industryErythrocyte indicesmedia_common.quotation_subjectBlood viscosityPhysiologySmall sampleHematologyMorbidly obeseBlood ViscosityErythrocyte aggregationObesity MorbidPhysiology (medical)Erythrocyte deformabilityMedicineHumansHemorheologyFemaleCardiology and Cardiovascular MedicinebusinessNormalitymedia_commonClinical hemorheology and microcirculation
researchProduct

COVID-19 disease - Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and manageme…

2020

Background Detailed temporal analyses of complete (full) blood count (CBC) parameters, their evolution and relationship to patient age, gender, co-morbidities and management outcomes in survivors and non-survivors with COVID-19 disease, could identify prognostic clinical biomarkers. Methods From 29 January 2020 until 28 March 2020, we performed a longitudinal cohort study of COVID-19 inpatients at the Italian National Institute for Infectious Diseases, Rome, Italy. 9 CBC parameters were studied as continuous variables [neutrophils, lymphocytes, monocytes, platelets, mean platelet volume, red blood cell count, haemoglobin concentration, mean red blood cell volume and red blood cell distribu…

Erythrocyte IndicesMaleViral DiseasesNeutrophilsPhysiologyclinical biomarkersRomeDisease030204 cardiovascular system & hematologyCardiovascular MedicineCohort StudiesLeukocyte CountWhite Blood Cells0302 clinical medicineMedical ConditionsAnimal CellsMedicine and Health SciencesRenal Failure030212 general & internal medicineLongitudinal StudiesLymphocytesSurvivorsCOPDMultidisciplinarymedicine.diagnostic_testQRComplete blood countMiddle AgedPrognosisBody FluidsInfectious DiseasesBloodSettore MED/38 - PEDIATRIA GENERALE E SPECIALISTICAPhysiological Parameterscovid-19; blood cell count; clinical biomarkerscovid-19Cardiovascular DiseasesNephrologyMedicineFemaleCellular TypesAnatomyMean Platelet VolumeCohort studyResearch ArticlePlateletsmedicine.medical_specialtyScienceImmune CellsImmunologyCardiology03 medical and health sciencesInternal medicinemedicineHumansObesityMean platelet volumeDemographyInflammationBlood Cellsbusiness.industryBody WeightBiology and Life SciencesRed blood cell distribution widthCovid 19Cell Biologymedicine.diseaseObesityBlood CountsAnisocytosisblood cell countbusinessBiomarkers
researchProduct